Rchr
J-GLOBAL ID:200901051785551291
Update date: Sep. 01, 2020
Tsuchiya Hiroyuki
ツチヤ ヒロユキ | Tsuchiya Hiroyuki
Affiliation and department:
Job title:
Associate Professor
Research field (3):
Gastroenterology
, Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (7):
nuclear receptors
, hepatocellular carcinoma
, HBV
, insulin resistance
, NAFLD/NASH
, hepatocarcinogenesis
, retinoids
Research theme for competitive and other funds (15):
- 2018 - 2019 肝癌を抑制する、核内受容体による新たな遺伝子発現制御システムの解明
- 2016 - 2019 レチノイドによる新たな発現制御メカニズムを介した肝癌抑制作用の解明
- 2016 - 2017 脂肪肝におけるエピジェネティック制御機構の解明
- 2015 - 2016 レチノイドによる新規薬理効果を介したNASH治療法の開発
- 2013 - 2015 糖尿病に伴う脂質代謝異常における核内受容体SHPの機能解明
- 2011 - 2013 レチノイン酸による肝臓インスリン感受性増強機構の解明と創薬開発への応用
- 2013 - 2013 核内受容体SHPによる肝臓の脂質代謝メカニズムの解明と代謝異常疾患の新規制御法の確立
- 2012 - 2013 糖尿病発症サルを用いたタミバテロンによるC型慢性肝炎治療効果の探索
- 2009 - 2011 Investigation of the effect of retinoids on hepatic iron overload in a mouse NAFLD model.
- 2011 - 2011 大規模ランダム配列組込み技術による新規ファンクショナルスクリーニングシステムの確立と抗腫瘍作用をもつオリゴ核酸の探索
- 2010 - 2010 インスリン感受性を増強する因子の探索
- 2005 - 2010 The effect of retinoids on biological functions of the liver
- 2007 - 2009 Comprehensive analysis of neogenin signaling factors in liver carcinogenesis.
- 2008 - 2008 除鉄を目的としたレチノイドによる慢性肝炎治療法の開発
- 2006 - 2007 レチノイドによる肝発癌制御機構におけるヘモジュベリン、ネオジェニンの機能解明
Show all
Papers (80):
-
Shotaro Hoi, Hiroyuki Tsuchiya, Noriko Itaba, Kyosuke Suzuki, Hiroyuki Oka, Minoru Morimoto, Tomoaki Takata, Hajime Isomoto, Goshi Shiota. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signaling. Clin Exp Pharmacol Physiol. 2020
-
Hiroyuki Tsuchiya, Masataka Amisaki, Ai Takenaga, Soichiro Honjo, Yoshiyuki Fujiwara, Goshi Shiota. HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma. Int J Mol Sci. 2019. 20. 22. 5714
-
Ryoma Asai, Hiroyuki Tsuchiya, Masataka Amisaki, Kazuki Makimoto, Ai Takenaga, Tomohiko Sakabe, Shotaro Hoi, Shigemi Koyama, Goshi Shiota. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line. Cancer Med. 2019. 8. 2. 773-782
-
Masataka Amisaki, Hiroyuki Tsuchiya, Tomohiko Sakabe, Yoshiyuki Fujiwara, Goshi Shiota. Identification of genes involved in the regulation of Telomerase Reverse Transcriptase in hepatocellular carcinoma. Cancer Sci. 2019. 110. 2. 550-560
-
Tetsuya Suzuki, Yusuke Wakao, Tadashi Watanabe, Mika Hori, Yoshito Ikeda, Hiroyuki Tsuchiya, Kentaro Kogure, Mariko Harada-Shiba, Masahiro Fujimuro, Hiroyuki Kamiya. No enhancing effects of plasmid-specific histone acetyltransferase recruitment system on transgene expression in vivo. Nucleosides, nucleotides & nucleic acids. 2019. 38. 12. 942-949
more...
MISC (23):
-
Zhihong Yang, Hiroyuki Tsuchiya, Sangmin Lee, Yuxia Zhang, Li Wang. Nuclear receptor Rev-Erba functions as a transcriptional activator of Chop to control SHP mediated alcoholic fatty liver. HEPATOLOGY. 2015. 62. 866A-867A
-
Sang Min Lee, Yuxia Zhang, Hiroyuki Tsuchiya, Rana Smalling, Anton Jetten, Li Wang. Circadian clock control of hepatic metabolism via nuclear receptor SHP. FASEB JOURNAL. 2014. 28. 1
-
Hiroyuki Tsuchiya, Yuxia Zhang, Sangmin Lee, Rana Smalling, Li Wang. Circadian clock mediates ER stress signaling in alcoholic fatty liver. FASEB JOURNAL. 2014. 28. 1
-
Hiroyuki Tsuchiya, Yuxia Zhang, Sangmin Lee, Rana Smalling, Li Wang. Nuclear receptor SHP is a key regulator of circadian clock mediated hyperhomocysteinemia induced by alcohol. HEPATOLOGY. 2014. 60. 786A-786A
-
Yuxia Zhang, Hiroyuki Tsuchiya, Olivier Barbier, Rana Smalling, James Cox, Don Delker, Curt H. Hagedorn, Li Wang. Long non-coding (Lnc) RNA H19 is a critical modulator of bile acid homeostasis. HEPATOLOGY. 2014. 60. 768A-768A
more...
Patents (6):
-
レチノイン酸受容体リガンドの抗腫瘍作用、発癌抑制作用を含めた種々の作用を決定する遺伝子の同定
-
レチノイン酸受容体リガンドによるインスリン抵抗性改善作用
-
核酸構築物及びそれを利用した標的領域への変異導入法
-
免疫活性増強剤とこれを用いた免疫活性の増強方法
-
DNA配列の塩基変換方法
more...
Education (3):
- 2002 - 2005 Hokkaido University
- 2000 - 2002 Hokkaido University
- 1996 - 2000 Hokkaido University
Professional career (1):
Work history (5):
- 2016/08 - 現在 Graduate School of Medicine, Tottori University Division of Molecular and Genetic Medicine Associate Professor
- 2014/10 - 2016/07 Graduate School of Pharmaceutical Sciences, Osaka University Specially Appointed Assistant Professor
- 2012/12 - 2014/09 Huntsman Cancer Institute, University of Utah School of Medicine Departments of Medicine and Oncological Sciences Research Scholar
- 2010/04 - 2012/11 Kyoto Pharmaceutical University Department of Biophysical Chemistry Lecturer
- 2005/04 - 2010/03 Graduate School of Medicine, Tottori University Division of Molecular and Genetic Medicine, Department of Genetic Medicine and Regenerative Therapeutics Assistant Professor
Committee career (4):
- 2019/06 - 現在 Scientific Reports Editorial Board Member
- 2019/01 - 現在 European Journal of Pharmacology Editorial Board Member
- 2018/12 - 現在 Cancers - Special Issue "Liver Cancer and Potential Therapeutic Targets" Guest Editor
- 2020/07 - 2021/02 Genes - Special Issue "Development of New Treatment by Identifying and Targeting Pathogenic Abnormalities of Genes" Guest Editor
Awards (6):
- 2014 - American Physiological Society Poster Award (Experimental Biology 2014, GI & Liver Trainee Poster Symposium) Circadian clock mediates ER stress signaling in alcoholic fatty liver.
- 2011 - ビタミンE研究会 奨励賞 ビタミンEの脂肪細胞における脂肪蓄積促進作用
- 2011 - 日本薬学会近畿支部 奨励賞 レチノイドシグナルを介したレプチン依存的インスリン抵抗性改善メカニズムの解析
- 2011 - 日本レチノイド研究会 武藤賞 レチノイドによるレプチン依存的インスリン抵抗性改善作用メカニズムの解明
- 2009 - The Japan Society of Hepatology AJINOMOTO Award
- 2007 - Asian Pacific Association for the Study of the Liver Young Investigator Award Effect Of Retinoic Acid On Iron Metabolism In Liver
Show all
Return to Previous Page